Andere talen Laurus Labs Limited Bombay S.E.

Aandelen

LAURUSLABS

INE947Q01028

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:50 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
449,7 ^INR	-0,12%		+3,86%	+4,54%

25/04	Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024
25/04	Laurus Labs Limited keurt bestuurswijzigingen goed	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Laurus Labs' Consolidated Profit Falls in Fiscal Q4	25/04
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024	25/04
Laurus Labs Limited Approves Board Changes	25/04
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	25/04
Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024	18/04
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company	15/04
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	26/01
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	25/01
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
INDIA STOCKS-IT drives losses in Indian shares ahead of Fed policy outcome	13/12
Indian shares set to open higher; focus turns to Fed policy	13/12
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	21/11
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	20/11
Laurus Labs Limited Announces Resignation of Chandrakanth Chereddi as Non-Executive Director	20-10-23
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	20-10-23
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20-10-23
Laurus Labs Limited agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.	11-09-23
India's Divi's Labs Q1 profit slumps on drug pricing pressures	14-08-23
Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%	31-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Laurus Labs Limited Bombay S.E.

Aandelen

LAURUSLABS

INE947Q01028

Andere talen

Filters